RETA 3-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Reata Pharmaceuticals (RETA) Investors with Losses to Contact Firm’s Attorneys About Opportunity to Lead Securities Fraud Action
February 15, 2022 17:30 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Reata Pharmaceuticals, Inc. (NASDAQ: RETA) investors with significant losses to submit your losses now. A securities fraud...
RETA 8-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Reata Pharmaceuticals (RETA) Investors with Losses to Contact Firm’s Attorneys Before Feb. 18th Deadline
February 10, 2022 09:35 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Reata Pharmaceuticals, Inc. (NASDAQ: RETA) investors with significant losses to submit your losses now. A securities fraud class...
RETA 13-DAY ALERT: Hagens Berman, National Trial Attorneys, Encourages Reata Pharmaceuticals (RETA) Investors with Losses to Contact Firm’s Attorneys Before Feb. 18th Deadline in Securities Fraud Case
February 05, 2022 09:46 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Feb. 05, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Reata Pharmaceuticals, Inc. (NASDAQ: RETA) investors with significant losses to submit your losses now. A securities fraud class...
RETA INVESTOR NOTICE: Hagens Berman, National Trial Attorneys, Encourages Reata Pharmaceuticals (RETA) Investors with Losses to Contact Firm’s Attorneys, Securities Class Action Pending
January 31, 2022 12:18 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Reata Pharmaceuticals, Inc. (NASDAQ: RETA) investors with significant losses to submit your losses now. A securities fraud...
RETA INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Reata Pharmaceuticals (RETA) Investors with Losses to Contact Firm’s Attorneys, Securities Class Action Pending
January 24, 2022 09:40 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Reata Pharmaceuticals, Inc. (NASDAQ: RETA) investors with significant losses to submit your losses now. A securities fraud...
RETA INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Reata Pharmaceuticals (RETA) Investors to Contact Firm’s Attorneys, Securities Class Action Filed
January 18, 2022 14:01 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Reata Pharmaceuticals, Inc. (NASDAQ: RETA) investors with significant losses to submit your losses now. A securities fraud...
RETA DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Reata Pharmaceuticals (RETA) Investors to Contact Firm’s Attorneys, Securities Class Action Pending
January 13, 2022 14:58 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Reata Pharmaceuticals, Inc. (NASDAQ: RETA) investors with significant losses to submit your losses now. A securities fraud...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Reata Pharmaceuticals (RETA) Investors to Contact Firm’s Attorneys, Deadline Approaching in Securities Class Action
January 08, 2022 13:05 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 08, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Reata Pharmaceuticals, Inc. (NASDAQ: RETA) investors with significant losses to submit your losses now. A securities fraud class...
RETA INVESTOR FRAUD: Hagens Berman, National Trial Attorneys, Encourages Reata Pharmaceuticals, Inc. (RETA) Investors to Contact Firm’s Attorneys, Securities Fraud Class Action Pending
January 03, 2022 13:42 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Reata Pharmaceuticals, Inc. (NASDAQ: RETA) investors with significant losses to submit your losses now. A securities fraud class...
RETA SECURITIES FRAUD: Hagens Berman, National Trial Attorneys, Encourages Reata Pharmaceuticals, Inc. (RETA) Investors to Contact Firm’s Attorneys, Securities Fraud Class Action Pending
December 28, 2021 09:36 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Dec. 28, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Reata Pharmaceuticals, Inc. (NASDAQ: RETA) investors with significant losses to submit your losses now. A securities fraud class...